Aug. 29 |
Introduction |
Aug. 31 |
Historical Development. Functional Groups |
Sept. 5 |
Sources of Drugs |
Sept. 7 |
Drug Development |
Sept. 12 |
Structure-Activity Relationships |
Sept. 14 |
Bioisosterism |
Sept. 19 |
ADME, Lipophilicity, Binding to Serum Proteins |
Sept. 21 |
Drug Metabolism |
Sept. 26 |
Drug Structure & Biological Activity |
Sept. 28 |
Acid-Base Chemistry |
Oct. 3 |
Drug Targets, Receptors |
Oct. 5 |
Examination #1 (material through September 28) |
Oct. 10 |
NO CLASS (follow Monday schedule) |
Oct. 12 |
Molecular Mechanisms of Drug Action |
Oct. 17 |
Drug-Receptor Interactions |
Oct. 19 |
Receptor Methodology |
Oct. 24 |
Drug-Enzyme Interactions |
Oct. 26 |
Mechanism-Based Enzyme Inhibition |
Oct. 31 |
Selectivity of Drug Action |
Nov. 2 |
Chemistry of Selected Drug Classes. Pharmacodynamic Drugs |
Nov. 7 |
Chemotherapeutic Drugs. Drug Resistance |
Nov. 9 |
Examination #2 (material through Nov. 2) |
Nov. 14 |
Antimicrobial Drugs |
Nov. 16 |
f3-Lactam Antibiotics |
Nov. 21 |
Antiviral Drugs |
Nov. 23 |
NO CLASS |
Nov. 28 |
Anticancer Drugs |
Nov. 30 |
Prodrugs |
Dec. 5 |
Drug Targeting. ADEPT |
Dec. 7 |
Chemistry of Drug Interactions & Drug Incompatibilities |